Showing 201-210 of 3397 results for "".
First, Do No Harm
https://practicaldermatology.com/conferences/scale-2023/first-do-no-harm/20206/Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss why dermatologists should report any side effects to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database.Therapeutic Advances and Fighting for Authorizations
https://reachmd.com/programs/practical-dermatology/therapeutic-advances-and-fighting-for-authorizations/35890/Joel L. Cohen, MD, FAAD, and Leon Kircik, MD, FAAD, discuss the latest developments in psoriasis and atopic dermatitis, as well as the challenges involved with fighting for prior authorizations for the best therapies, at Music City SCALE 2025.Pigmentation Disorders
https://practicaldermatology.com/topics/pigmentary-disorders/pigmentation-disorders/19730/Sunscreen may be the first, second, and third thing recommended for patients with pigmentation disorders, but what comes next? Joel Cohen, MD interviews Amit Pandya, MD to learn about treatment options and developments in the pipeline.Aloha Maui Derm
https://practicaldermatology.com/topics/psoriasis/aloha-maui-derm/19715/What is the magic that makes Maui Derm so special? Joel Cohen, MD and meeting founder and director George Martin, MD, go behind the scenes of one of the most popular meetings in dermatology.Rosacea Treatment Options and Strategies
https://reachmd.com/programs/practical-dermatology/rosacea-treatment-options-and-strategies/35893/Joel L. Cohen, MD, FAAD, and Hilary Baldwin, MD, talk at Music City SCALE 2025 about the latest treatment options for rosacea and strategies for getting patient buy-in.Fractional Lasers for NMSC and More
https://practicaldermatology.com/conferences/scale-2025/fractional-lasers-for-nmsc-and-more/35876/Joel L. Cohen, MD, FAAD, and Matthew M. Avram, MD, talk about research involving fractional lasers, including as part of combination treatments for nonmelanoma skin cancer, at Music City SCALE 2025.Skin of Color Society in NYC; Highlights from 2017
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-skin-of-color-society-in-nyc-highlights-from-2017/18359/In this special edition of DermWireTV, Seemal Desai, MD offers a recap of the Skin of Color Society's media day in New York. Plus, a look at the most-read and viewed content from Practical Dermatology® magazine and DermTube.com, featuring Heidi Waldorf, MD, Linda Stein-Gold, MD, Ted Rosen, MD, JoelHow Air Pollution Affects the Skin
https://practicaldermatology.com/programs/practical-dermatology/how-air-pollution-affects-the-skin/24041/An Interview with Dr. Mark Birch-MachinBest Practices: Allan Wirtzer, MD on Leadership
https://practicaldermatology.com/topics/practice-management/best-practices-allan-wirtzer-md-on-leadership/18592/Sometimes the most important role of a physician is leader. Whether in your practice or for your specialty overall, doctors must lead the charge forward. In this edition of Best Practices, host Joel L. Cohen, MD talks to Allan S. Wirtzer, MD about issues affecting medicine, including coding, and theDermWireTV: Candela + Merz Aesthetics Partnership, COVID-19 Vaccines & Fillers, Almirall's Klisyri, MetSyn & PsO
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-candela-merz-aesthetics-partnership-covid-19-vaccines-and-fillers-almiralls-klisyri-metsyn-and-pso/19893/Klisyri® (tirbanibulin) ointment 1% from Almirall will be available for treatment of AKs by the end of this quarter; Ayman Grada, MD discusses. Are patients who have received dermal filler injections at risk for developing reactions to the COVID-19 vaccine? Joel L. Cohen, MD and Doris Day, MD weigh